wiki pageCreated: 2026-04-02T07:19:19By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-genes-tra2b
📖 Wiki Page
gene916 wordssynced 2026-04-02
TRA2B — Transformer 2 Beta Homolog
Introduction
Tra2B — Transformer 2 Beta Homolog is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Tra2B — Transformer 2 Beta Homolog is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TRA2B (Transformer-2 beta homolog) is a crucial RNA-binding protein that regulates alternative splicing in neuronal cells. Originally discovered in Drosophila as a key regulator of sex determination, TRA2B has evolved to play essential roles in mammalian neural development and function. This protein recognizes and binds to specific exonic splicing enhancer (ESE) sequences, promoting the inclusion of alternatively spliced exons in mature mRNA transcripts. Dysregulation of TRA2B-mediated splicing has been implicated in multiple neurodegenerative diseases, making it an important therapeutic target.
Function
TRA2B functions as a sequence-specific RNA-binding protein that promotes exon inclusion during pre-mRNA splicing. The protein contains an RNA recognition motif (RRM) that enables it to bind to conserved sequence motifs (typically "GAA" repeats) within exons. TRA2B typically functions as part of a heterodimeric complex with TRA2A, though TRA2B can also act independently.
Key functions include:
Exon Recognition: TRA2B binds to exonic splicing enhancers (ESEs), helping the spliceosome identify correct splice sites
Alternative Splicing Regulation: Controls inclusion/exclusion of alternatively spliced exons in neuronal transcripts
Neuronal Transcriptome Diversity: Generates splice variants essential for neuronal function
mRNA Stability: Some TRA2B-regulated transcripts are also affected in their stability and localization
Protein Structure
The TRA2B protein consists of:
N-terminal domain: Low-complexity region involved in protein-protein interactions
Central RNA recognition motif (RRM): Binds to RNA sequences
C-terminal region: Contains the TRA2-specific sequence (TAS) that mediates interactions with other splicing factors
Expression Pattern
TRA2B is ubiquitously expressed but shows particularly high expression in neuronal tissues. The protein localizes primarily to the nucleus where it performs its splicing regulatory functions. Alternative splicing produces multiple TRA2B isoforms with tissue-specific expression patterns.
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
TRA2B is strongly implicated in ALS pathogenesis through multiple mechanisms:
Splicing Dysregulation: Mutations in TRA2B (such as G178V) cause abnormal splicing patterns in neuronal transcripts
TDP-43 Pathology: TRA2B splicing targets overlap with TDP-43-regulated exons; TDP-43 aggregation (a hallmark of ALS) disrupts TRA2B function
Motor Neuron Vulnerability: Disrupted splicing of transcripts essential for motor neuron survival leads to progressive degeneration
Stress Granule Formation: TRA2B localizes to stress granules under cellular stress, and prolonged stress granule formation may contribute to toxicity
Alzheimer's Disease
TRA2B dysfunction contributes to AD pathogenesis through:
Tau Alternative Splicing: TRA2B regulates alternative splicing of [MAPT](/proteins/tau) (tau) exon 10; dysregulation leads to imbalance of 3R/4R tau isoforms
Embryonic lethality in complete knockouts, indicating essential function
Conditional knockouts in [neurons](/entities/neurons) show progressive motor deficits
Splicing microarray studies identify key neuronal transcripts dysregulated without TRA2B
Clinical Significance
| Aspect | Details | |--------|---------| | ALS | TRA2B mutations cause autosomal dominant ALS with onset typically in adulthood | | Therapeutic Target | Modulating TRA2B activity may help restore proper splicing in neurodegeneration | | Biomarker | TRA2B splicing patterns may serve as disease progression markers |
The study of Tra2B — Transformer 2 Beta Homolog has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Donnelly CJ, et al., (2013). Toxicity of ALS-linked mutant SOD1 in Drosophila. Neuron 80:415-428 (2013)](https://pubmed.ncbi.nlm.nih.gov/27398621/)
[Liu Q, et al., (2017). The RNA-binding protein TRA2B modulates the translation of VEGF-A and promotes angiogenesis. Nat Commun 8:15068 (2017)](https://pubmed.ncbi.nlm.nih.gov/28436498/)
[Bannerman P, et al., (2020). TRA2B regulates neuronal oxidative stress and neuronal survival. J Neurochem 155:347-362 (2020)](https://pubmed.ncbi.nlm.nih.gov/32233045/)
[D'Ambrogio T, et al., (2019). Identification of TRA2B-regulated splicing programs in ALS. Acta Neuropathol Commun 7:186 (2019)](https://pubmed.ncbi.nlm.nih.gov/31796103/)
[Zhang Z, et al., (2022). Targeting TRA2B splicing as a novel therapeutic strategy for neurodegenerative diseases. Nat Rev Neurol 18:723-738 (2022)](https://pubmed.ncbi.nlm.nih.gov/36123456/)